His research interest includes tyrosine kinase signaling, epigenetic regulation of transcription and drug discovery. His group has extensively studied kinase and epigenetic signaling in prostate and breast cancers and has developed many new inhibitors to overcome growth of these tumor cells.
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this. Please refer to our "privacy statement" and our "terms of use" for further information.
